Oncology Stock Spikes 24% Amidst Investment Firm's New Price Target

In a significant development that has caught the attention of investors, Cardiff Oncology Inc. (NASDAQ: CRDF) saw an impressive 24% surge in their stock price yesterday, closing at $3.58. This sudden upswing comes amidst positive sentiments from leading investment banking and institutional securities firm, Piper Sandler, which has set a bullish price target of $7. $Cardiff Oncology (CRDF.US)$